Katharina Grabmeier‐Pfistershammer

Author

Also Known As

F Wit, K Grabmeier-Pfistershammer, K Grabmeier‐Pfistershammer, K Pfistershammer, K. Grabmeier-Pfistershammer, K. Grabmeier‐Pfistershammer, K. Pfistershammer, K., Grabmeier-Pfistershammer, Katharina Grabmeier-Pfistershammer, Katharina Grabmeier‐Pfistershammer

148

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna University of Zurich University Hospital of Zurich University College London Rigshospitalet

About

Katharina Grabmeier‐Pfistershammer is an author at Medical University of Vienna specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.9K
2	Public Health	9	9	778
3	Cell Biology	6	6	884
4	Allergy	3	3	258
5	Social Sciences	1	1	16

Katharina Grabmeier‐Pfistershammer

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Mpox in people with advanced HIV infection: a global case series Andrea Alemany, Michael Marks, Jezer I Lezama Mora, The Lancet Advanced Hiv InfectionSexual HealthTreatment And PreventionHuman RetrovirusGlobal Health	2023	452
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma Johannes Griss, Wolfgang Bauer, Christine Wagner, Nature Communications Cancer ImmunosurveillanceHuman MelanomaMelanomaImmunologyTumor Immunity	2019	360
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction Judith Leitner, Christoph Klauser, Winfried F. Pickl, European Journal of Immunology	2009	282
Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains Peter Steinberger, Otto Majdic, Sophia Derdak, The Journal of Immunology	2004	266
Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1 Sabrina Jutz, Judith Leitner, Klaus G. Schmetterer, Journal of Immunological Methods Transcriptional RegulationSignal TransductionTriple Parameter ReporterSignaling PathwayImmunology	2016	203
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling Annika De Sousa Linhares, Claire Battin, Sabrina Jutz, Scientific Reports	2019	189
Detection and Prediction of Active Tuberculosis Disease by a Whole‐Blood Interferon‐γ Release Assay in HIV‐1–Infected Individuals Maximilian C. Aichelburg, Armin Rieger, F Breitenecker, Clinical Infectious Diseases	2009	164
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium Bastian Neesgaard, Lauren Greenberg, José M. Miró, The Lancet HIV Cardiovascular EpidemiologyCardiovascular DiseaseTreatment And PreventionHuman RetrovirusAntiviral Therapy	2022	126
Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs Nanina Anderegg, Klea Panayidou, Yao Abo, Clinical Infectious Diseases	2017	119
A Comprehensive and Quantitative Analysis of the Major Specificities in Rabbit Antithymocyte Globulin Preparations Irene Popow, Judith Leitner, Katharina Grabmeier‐Pfistershammer, American Journal of Transplantation Antithymocyte GlobulinAutoimmune DiseaseAllergyLaboratory ImmunologyMedicine	2013	112

Page 1